Analysis on the $12.8Bn Global Blood Glucose Monitoring Market, 2019: Coverage Through 2012-2024 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 2, 2019--The “Blood Glucose Monitoring Market (2012 - 2024)” report has been added to ResearchAndMarkets.com’s offering.
The global blood glucose monitoring market is expected to register a CAGR of 11.88% during the forecast period of 2019-2024; the market is estimated to reach USD 12.8 billion by 2019.
Blood glucose monitoring devices are used for effective diabetes diagnosis and treatment. A rise in the diabetic population drives the market by increasing the use of blood glucose monitoring devices. Obesity is also considered as one of the major factors contributing to the disease, primarily Type 2 diabetes.
Also, other factors, such as technological innovations and advancements, give much convenience in measuring the blood glucose levels. One such advancement in monitoring the blood glucose level is established with continuous glucose monitoring devices. These devices help in the early detection of hypo and hyperglycemic conditions, which tend to drive the market for glucose monitoring.
Key Market Trends
Glucometer Consumables (Test Strips & Lancets) Occupy the Highest Market Share
Although CGM is an advanced way for people living with diabetes to check glucose readings in real-time, SMBG is the most preferred device by the patients due to its economic affordability and less sophisticated usage when compared to CGM. The SBGM occupies more than 87% of the share in the blood glucose monitoring market.
The further segmented market of SBGM gives an understanding that the disposable consumables - test strips and lancets, occupy the larger market share when compared to glucometer devices. However, the CAGR for glucometer devices is high.
CGM, though it provides real-time data of blood glucose levels for patients, has low adaptability in the emerging markets. However, CGM’s adaptability is high in developed markets. The cost factor is a major concern for the low growth of CGM in emerging markets.
North America is Leading the Market
In 2018, North America, especially the United States, held the largest share in the blood glucose monitoring market, due to the large patient pool and wide acceptance of advanced technologies followed by Europe, which showed moderate growth. Asia-Pacific, Latin America, and the Middle East & Africa showed low growth due to economic affordability.
The blood glucose monitoring market is highly fragmented with few major manufacturers boasting a global market presence, while the remaining manufacturers confining to the other local or region-specific manufacturers.
Mergers and acquisitions that happened between the players in the recent past helped the companies to strengthen their market presence. For example, Dexcom has partnered with Julphar to have its market presence in the Middle Eastern region.
Key Topics Covered
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.4 Porter’s Five Forces Analysis
5 MARKET SEGMENTATION
5.1 Blood Glucose Monitoring
5.1.1 Self-Monitoring Blood Glucose
18.104.22.168 By Component (Market Size, Value and Volume)
22.214.171.124.1 Glucometer Devices
126.96.36.199.2 Test Strips
188.8.131.52 By End User
184.108.40.206.1 Hospital (Market Size, Value and Volume)
220.127.116.11.1.1 Glucometer Devices
18.104.22.168.1.2 Test Strips
22.214.171.124.2 Personal (Market Size, Value and Volume)
126.96.36.199.2.1 Glucometer Devices
188.8.131.52.2.2 Test Strips
5.1.2 Continuous Blood Glucose Monitoring
184.108.40.206 By Component (Market Size, Value and Volume)
5.2.1 North America
5.2.3 Latin America
5.2.5 Middle East and Africa
6 MARKET INDICATORS
6.1 Type-1 Diabetes population (2013-2024)
6.2 Type-2 Diabetes population (2013-2024)
7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Abbott Diabetes Care
7.1.3 Johnson & Johnson
7.1.7 Ascensia Diabetes Care
7.1.8 Agamatrix Inc.
7.1.9 Bionime Corporation
7.2 Company Share Analysis
7.2.2 Johnson & Johnson
7.2.3 Abbott Diabetes Care
8 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/research/fvc43s/analysis_on_the?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190402005693/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Glucose Testing,Diabetes Devices
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES DIABETES
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 04/02/2019 09:46 AM/DISC: 04/02/2019 09:46 AM